North America Hemodialysis and Peritoneal Dialysis Market Forecast to 2028

Report Code : BMIRE00025835 | Region : North America | Industry : Medical Device | Published Date : 12/Sep/2022
North America Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Hemodialysis and Peritoneal Dialysis), Product (Devices, Consumables, and Services), and End User (Hospital-Based and Home-Based)

The hemodialysis and peritoneal dialysis market in North America is expected to grow from US$ 31,852.39 million in 2022 to US$ 45,277.56 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.

The rising prevalence of kidney diseases is the major factor driving the North America hemodialysis and peritoneal dialysis market. Chronic kidney disease (CKD) and acute kidney injury (AKI) are conditions in which the kidneys are damaged and cannot filter blood properly. Because of this, excess fluid and waste from blood remain in the body, which may cause other health problems such as heart disease and stroke. CKD usually worsens over time, even though treatment has shown slow progression. If CKD is left untreated, it can progress to kidney failure and early cardiovascular disease. In CKD, when the kidneys stop working, dialysis or kidney transplant is needed for survival. When treated with dialysis or kidney transplant, this kidney failure is called end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), approximately 36 million adults are suffering from CKD in the US. Further, every 24 hours, 360 people begin dialysis treatment for kidney failure. In 2017, 697.5 million cases of CKD (all stages) were recorded worldwide, with a North American prevalence of 9.1%.

In the past few years, the requirement for dialysis has increased. For instance, according to the National Kidney Foundation, in 2018, 785,883 US residents faced kidney failure, of which 554,038 received dialysis. Likewise, according to the data published by the Food & Drug Administration (FDA), about 10,000 children in the US develop AKI. These children have a survival rate of around 38% to 43%.

The increasing prevalence of ESRD is also one of the major factors driving the market. For instance, according to the United States Renal Data System (USRDS), nearly 786,000 people in the country are living with end-stage kidney disease (ESKD), also known as end-stage renal disease (ESRD). Thus, the increasing prevalence of chronic kidney disease, acute kidney injury, and end-stage renal disease, which leads to the condition of dialysis, is driving the hemodialysis and peritoneal dialysis market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America hemodialysis and peritoneal dialysis market. The North America hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.

North America Hemodialysis and Peritoneal DialysisMarket Revenue and Forecast to 2028 (US$ Million)

North America Hemodialysis and Peritoneal Dialysis Market Segmentation

The North America hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country. Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share. Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022. Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022. Based on country, the North America hemodialysis and peritoneal dialysis market is segmented into the US, Canada, and Mexico. The US is anticipated to hold the largest market share in 2022.

Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Evoqua Water Technologies LLC. (Mar Cor Purification); Fresenius Medical Care AG & Co KGaA; Nipro Medical Corporation; and Rockwell Medical, Inc. are among the leading companies operating in the North America hemodialysis and peritoneal dialysis market.

The List of Companies - North America Hemodialysis and Peritoneal Dialysis Market

● Asahi Kasei Medical Co., Ltd.

● B. Braun Melsungen AG

● Baxter International Inc.

● DaVita Inc.

● Dialife SA

● Evoqua Water Technologies LLC. (Mar Cor Purification)

● Fresenius Medical Care AG & Co KGaA

● Nipro Medical Corporation

● Rockwell Medical, Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Hemodialysis and Peritoneal Dialysis Market – By Type

1.3.2 North America Hemodialysis and Peritoneal Dialysis Market – By Product

1.3.3 North America Hemodialysis and Peritoneal Dialysis Market – By End User

1.3.4 North America Hemodialysis and Peritoneal Dialysis Market – By Country

2. North America Hemodialysis and Peritoneal Dialysis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Hemodialysis and Peritoneal Dialysis Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Expert Opinion

5. North America Hemodialysis and Peritoneal Dialysis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Kidney Diseases

5.1.2 Increasing Cases of Diabetes

5.2 Market Restraints

5.2.1 Risks and Complications with Dialysis

5.3 Market Opportunities

5.3.1 Surge in Preference of Patients for Home Care Dialysis

5.4 Future Trends

5.4.1 Market Strategies by Major Players

5.5 Impact Analysis

6. Haemodialysis and Peritoneal Dialysis Market– North America Analysis

6.1 North America Haemodialysis and Peritoneal Dialysis Market Revenue Forecast and Analysis

6.2 North America Haemodialysis and Peritoneal Dialysis Market, By Country - Forecast and Analysis

7. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028– by Type

7.1 Overview

7.2 North America Haemodialysis and Peritoneal Dialysis Market, By Type, 2022 & 2028 (%)

7.3 Haemodialysis

7.3.1 Overview

7.3.2 Haemodialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Peritoneal Dialysis

7.4.1 Overview

7.4.2 Peritoneal Dialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)

8. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 – Product

8.1 Overview

8.2 North America Haemodialysis and Peritoneal Dialysis Market Share by Product Segment - 2021 & 2028 (%)

8.3 Devices

8.3.1 Overview

8.3.2 Devices: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)

8.4 Consumables

8.4.1 Overview

8.4.2 Consumables: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)

8.5 Services

8.5.1 Overview

8.5.2 Services: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)

9. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 – End User

9.1 Overview

9.2 North America Haemodialysis and Peritoneal Dialysis Market Share by End User Segment - 2021 & 2028 (%)

9.3 Hospital-Based

9.3.1 Overview

9.3.2 Hospital-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)

9.4 Home-Based

9.4.1 Overview

9.4.2 Home-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)

10. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 – Country Analysis

10.1 Overview

10.1.1 North America: Haemodialysis and Peritoneal Dialysis Market, by Country, 2022 & 2028 (%)

10.1.1.1 US: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 US: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 US: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)

10.1.1.1.4 US: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)

10.1.1.1.5 US: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)

10.1.1.2 Canada: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Canada: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)

10.1.1.2.4 Canada: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)

10.1.1.2.5 Canada: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)

10.1.1.3 Mexico: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 Mexico: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)

10.1.1.3.4 Mexico: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)

10.1.1.3.5 Mexico: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)

11. Hemodialysis and Peritoneal Dialysis Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Hemodialysis and Peritoneal Dialysis Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 Fresenius Medical Care AG & Co KGaA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 DaVita Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Baxter International Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 B. Braun Melsungen AG

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Nipro Medical Corporation

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Evoqua Water Technologies LLC. (Mar Cor Purification)

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Asahi Kasei Medical Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Rockwell Medical, Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Dialife SA

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1.             US Haemodialysis and Peritoneal Dialysis Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Haemodialysis and Peritoneal Dialysis Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Haemodialysis and Peritoneal Dialysis Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Canada: Haemodialysis and Peritoneal Dialysis Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada Haemodialysis and Peritoneal Dialysis Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Haemodialysis and Peritoneal Dialysis Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Mexico: Haemodialysis and Peritoneal Dialysis Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico Haemodialysis and Peritoneal Dialysis Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Haemodialysis and Peritoneal Dialysis Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Organic Developments in the Hemodialysis and Peritoneal Dialysis Market

Table 11.          Inorganic Developments in the Hemodialysis and Peritoneal Dialysis Market

Table 12.          Glossary of Terms

The List of Companies - North America Hemodialysis and Peritoneal Dialysis Market

● Asahi Kasei Medical Co., Ltd.

● B. Braun Melsungen AG

● Baxter International Inc.

● DaVita Inc.

● Dialife SA

● Evoqua Water Technologies LLC. (Mar Cor Purification)

● Fresenius Medical Care AG & Co KGaA

● Nipro Medical Corporation

● Rockwell Medical, Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America hemodialysis and peritoneal dialysis market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America hemodialysis and peritoneal dialysis market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the hemodialysis and peritoneal dialysis market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

CHOOSE LICENCE TYPE
(North America Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
TOP
Quick Enquiry